Prostacyclins, thromboxanes and cardiovascular disease
- 31 March 1979
- journal article
- review article
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 4 (3) , 68-71
- https://doi.org/10.1016/0968-0004(79)90266-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIETPublished by Elsevier ,2021
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- An intervention study—The aspirin myocardial infarction studyLipids, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- Prostaglandin Endoperoxides IX. Characterization of Rabbit Aorta Contracting Substance (RCS) from Guinea Pig Lung and Human PlateletsActa Physiologica Scandinavica, 1975
- Anti-inflammatory drugs in experimental atherosclerosis Part 1. Relative potencies for inhibiting plaque formationAtherosclerosis, 1973
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- The enzymatic formation of prostaglandin E2 from arachidonic acid prostaglandins and related factors 32Biochimica et Biophysica Acta (BBA) - General Subjects, 1964
- PROCEEDINGS OF THE PHYSIOLOGICAL SOCIETYThe Journal of Physiology, 1935